StockData
Glucotrack, Inc. logo

Glucotrack, Inc. (GCTK) stock

GCTKOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30
$0.68−0.04 (-5.56%)

Close on Oct 19, 2026Market cap $3.43MP/E 0.0Yield –

Glucotrack shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Glucotrack's shares outstanding was 5M at Jun 30, 2026. For fiscal 2025 it was 1M, up 11186.5% from the year before. Over ten years it grew -7.8% a year on average. The highest annual figure on record is 52M in fiscal 2021.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 20251M+11186.5%
FY2024Dec 31, 20240M+59.0%
FY2023Dec 31, 20230M-93.3%
FY2022Dec 31, 20220M-99.9%
FY2021Dec 31, 202152M+2.5%
FY2020Dec 31, 202050M+26.4%
FY2019Dec 31, 201940M+1745.1%
FY2018Dec 31, 20182M+33.6%
FY2017Dec 31, 20172M+8.6%
FY2016Dec 31, 20161M+5.7%
FY2015Dec 31, 20151M+2.4%
FY2014Dec 31, 20141M+0.4%
FY2013Dec 31, 20131M+0.2%
FY2012Dec 31, 20121M+4.4%
FY2011Dec 31, 20111M+26.2%
FY2010Dec 31, 20101M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 20265M+913.0%
Q1 FY2026Mar 31, 20262M+867.3%
Q4 FY2025Dec 31, 20251M+10490.2%
Q3 FY2025Sep 30, 20251M+19188.2%
Q2 FY2025Jun 30, 20250M+10734.9%
Q1 FY2025Mar 31, 20250M+3970.8%
Q4 FY2024Dec 31, 20240M-88.7%
Q3 FY2024Sep 30, 20240M-93.5%
Q2 FY2024Jun 30, 20240M-91.2%
Q1 FY2024Mar 31, 20240M-91.9%
Q3 FY2023Sep 30, 20230M+48.4%
Q2 FY2023Jun 30, 20230M+39.3%
Q1 FY2023Mar 31, 20230M+0.3%
Q4 FY2022Dec 31, 20220M-99.9%
Q3 FY2022Sep 30, 20220M-99.9%
Q2 FY2022Jun 30, 20220M-99.9%
Q1 FY2022Mar 31, 20220M-99.9%
Q4 FY2021Dec 31, 202152M-0.1%
Q3 FY2021Sep 30, 202152M+0.2%
Q2 FY2021Jun 30, 202151M+0.2%
Q1 FY2021Mar 31, 202152M+10.4%
Q4 FY2020Dec 31, 202052M+23.3%
Q3 FY2020Sep 30, 202051M+23.7%
Q2 FY2020Jun 30, 202051M+33.7%
Q1 FY2020Mar 31, 202047M+26.6%
Q4 FY2019Dec 31, 201942M+1474.6%
Q3 FY2019Sep 30, 201942M+1863.9%
Q2 FY2019Jun 30, 201938M+1882.3%
Q1 FY2019Mar 31, 201937M+1945.4%
Q4 FY2018Dec 31, 20183M+58.8%
Q3 FY2018Sep 30, 20182M+29.2%
Q2 FY2018Jun 30, 20182M+21.8%
Q1 FY2018Mar 31, 20182M+16.5%
Q4 FY2017Dec 31, 20172M+10.2%
Q3 FY2017Sep 30, 20172M+10.0%
Q2 FY2017Jun 30, 20172M–
Q1 FY2017Mar 31, 20172M–
Q4 FY2016Dec 31, 20162M–
Q3 FY2016Sep 30, 20161M–

More Glucotrack figures

See a number that looks wrong?